Cost-effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation

被引：0
|
作者：
Shah, Shimoli V. [1 ]
Gage, Brian F. [1 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
来源：
CIRCULATION | 2010年 / 122卷 / 21期
关键词：
Cost-effectiveness; Atrial fibrillation; Thrombin inhibitors; Stroke; Anticoagulants;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A16179
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Cost-Effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation
    Shah, Shimoli V.
    Gage, Brian F.
    CIRCULATION, 2011, 123 (22) : 2562 - 2570
  • [2] COST-EFFECTIVENESS OF DABIGATRAN FOR STROKE PREVENTION IN ATRIAL FIBRILLATION IN CHINA
    Wan, Y.
    Davies, G. M.
    Lu, Z. G.
    Chen, F.
    Chen, J.
    VALUE IN HEALTH, 2014, 17 (03) : A114 - A114
  • [3] Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation in Switzerland
    Pletscher, Mark
    Plessow, Rafael
    Eichler, Klaus
    Wieser, Simon
    SWISS MEDICAL WEEKLY, 2013, 143
  • [4] Cost-effectiveness of stroke prophylaxis for nonvalvular atrial fibrillation
    Kan, BD
    Katz, DA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (12): : 909 - 909
  • [5] COST-EFFECTIVENESS BASED PRICING FOR DABIGATRAN FOR THE PRIMARY PROPHYLAXIS OF STROKE IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION
    Patel, Rajesh
    Medow, Mitchell
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2010, 25 : 249 - 249
  • [6] Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation
    Freeman, James V.
    Zhu, Ruo P.
    Owens, Douglas K.
    Garber, Alan M.
    Hutton, David W.
    Go, Alan S.
    Wang, Paul J.
    Turakhia, Mintu P.
    ANNALS OF INTERNAL MEDICINE, 2011, 154 (01) : 1 - U129
  • [7] Cost-effectiveness of stroke prophylaxis for nonvalvular atrial fibrillation - Reply
    Gage, BF
    Cardinalli, AB
    Albers, GW
    Owens, DK
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (12): : 910 - 910
  • [8] COST-EFFECTIVENESS OF DABIGATRAN COMPARED TO GENOTYPE-GUIDED WARFARIN DOSING FOR STROKE PROPHYLAXIS IN ATRIAL FIBRILLATION PATIENTS
    Lim, K. J.
    Tan, D. S. Y.
    Wee, H. L.
    VALUE IN HEALTH, 2012, 15 (07) : A602 - A602
  • [9] Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation
    Harrington, Amanda R.
    Armstrong, Edward P.
    Nolan, Paul E., Jr.
    Malone, Daniel C.
    STROKE, 2013, 44 (06) : 1676 - +
  • [10] COST-EFFECTIVENESS ANALYSIS OF DABIGATRAN FOR THE PREVENTION OF STROKE IN IRANIAN ATRIAL FIBRILLATION PATIENTS
    Keshavarz, K.
    Meshkini, Hashemi A.
    Nikfar, S.
    Ashkuh, M. S.
    Sanati, E.
    VALUE IN HEALTH, 2016, 19 (07) : A654 - A654
12345